Hypokalaemia
Description
- K+ <3.5 mmol/L; severe <2.5 mmol/L
- Reflects either transcellular shift or a true total-body deficit - management differs
Epidemiology
- Common - up to 20% of hospitalised patients, mostly diuretic-related
- More clinically dangerous in patients with structural heart disease or on digoxin
Aetiopathogenesis
Transcellular shift (no true deficit)
- Insulin, beta-agonists (salbutamol), alkalosis, refeeding syndrome, hypothermia, periodic paralysis
Renal loss
- Diuretics (loop, thiazide) - commonest cause overall
- Mineralocorticoid excess - primary hyperaldosteronism, Cushing's, renin-secreting tumour, liquorice
- Renal tubular acidosis type 1 (distal) and type 2 (proximal) - both cause hypokalaemia (type 4 causes hyperkalaemia)
- Bartter syndrome (loop mimic), Gitelman syndrome (thiazide mimic) - both present with metabolic alkalosis
- Magnesium depletion - impairs renal K+ conservation; hypokalaemia refractory to replacement until Mg2+ corrected
Extrarenal loss
- Vomiting (also alkalosis + volume depletion -> secondary hyperaldosteronism worsens K+ loss), diarrhoea (usually with acidosis), laxative abuse, villous adenoma
Diagnosis
Confirm and characterise
- Repeat to exclude spurious result (haemolysis, delayed processing, marked leucocytosis)
- Urine K+/creatinine or 24h urine K+ - distinguishes renal (inappropriately high) from extrarenal loss (appropriately low, kidney conserving K+)
- Check Mg2+, VBG (acid-base pattern narrows the differential), BP (hypertension suggests mineralocorticoid excess)
ECG changes - correlate poorly with severity but assess if K+ <3.0 or symptomatic
- Flattened/inverted T waves, U waves, ST depression, PR prolongation
- Severe - arrhythmia, especially torsades de pointes, digoxin toxicity potentiated
Management
Replacement
- Oral replacement preferred if K+ >2.5-3.0 and asymptomatic
- IV replacement if severe, symptomatic, ECG changes, or unable to tolerate oral
- Max peripheral IV rate ~10 mmol/h (up to 20 mmol/h with continuous cardiac monitoring via central line in critical care)
- Never as an IV push/bolus - fatal arrhythmia risk
- Check and correct Mg2+ simultaneously - hypokalaemia will not correct with hypomagnesaemia untreated
- Recheck K+ 2-4 hourly during active IV replacement
Treat the cause
- Reduce/switch diuretic, add potassium-sparing agent (spironolactone, amiloride) if diuretic-induced and ongoing need
- Investigate for mineralocorticoid excess if hypertensive + unprovoked hypokalaemia
Associations
- Rhabdomyolysis (severe, prolonged hypokalaemia)
- Ileus, muscle weakness/paralysis (periodic paralysis)
- Nephrogenic diabetes insipidus (chronic hypokalaemia impairs urinary concentration)
- Digoxin toxicity potentiation
Natural history & complications
- Mild, easily corrected hypokalaemia - benign
- Severe or refractory hypokalaemia - investigate for an underlying cause (RTA, mineralocorticoid excess, Bartter/Gitelman) rather than treating indefinitely with supplements alone
- Recurrent hypokalaemia with hypertension warrants aldosterone:renin ratio testing
🔒
6 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access